Related Experiment Video
Updated: Sep 26, 2026

A Multicenter MRI Protocol for the Evaluation and Quantification of Deep Vein Thrombosis
Published on: June 2, 2015
Interventions in Acute Venous Thrombosis: Proceedings from the Society of Interventional Radiology Foundation
Vivian L Bishay1, Tanvir Agnihotri1, Minhaj S Khaja2
1Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, New York.
Abstract:
Acute deep vein thrombosis (DVT) is associated with substantial long-term morbidity, primarily through the development of postthrombotic syndrome (PTS). While endovascular strategies aim to clear thrombus and preserve venous patency, randomized evidence has not demonstrated consistent reductions in overall PTS across a broad DVT patient population. New clinical and basic research into individual variability in vein wall inflammation and fibrosis, ability to mount endogenous fibrinolysis, response to antithrombotic therapy, and impact of timing of treatment initiation continue to refine our understanding of overall susceptibility to PTS. Thrombectomy devices remain focused on short-term venous patency, while freedom from PTS is achieved with long-term venous patency, minimization of recurrent thrombotic episodes, and a reduction of perivenous inflammation. Endovascular DVT trial end points remain heterogeneous and frequently emphasize anatomic thrombus reduction without standardized physiologic, biologic, or patient-centered correlates. Recognizing these gaps in evidence, methodology, and end point standardization, the Society of Interventional Radiology (SIR) Foundation convened a multidisciplinary Research Consensus Panel to define research priorities and establish standardized frameworks for outcome determination in acute DVT intervention. Expert panelists representing interventional radiology, vascular surgery, vascular medicine, and hematology delivered structured presentations, followed by moderated discussion and weighted ranking of proposed research initiatives. The resulting agenda emphasizes biologically informed patient selection, standardized anatomic and physiologic metrics, validated acute DVT severity instruments, longitudinal biomarker integration, and incorporation of economic and quality-of-life measures to advance precision and clinically meaningful DVT investigation.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis I: Introduction
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care